DexCom, Inc.
NASDAQDexCom enters the week after a 29% one-month rally with an unusual split: analysts are lifting targets in its wake, yet options traders just registered their most defensive positioning of the year — a tension worth watching heading into July earnings. The sharpest signal this week is in options. The put/call ratio jumped to 1.02 on June 9, well above its 20-day average of 0.86 and…
Snapshot as of 30 Jun 2026
DexCom enters the week after a 29% one-month rally with an unusual split: analysts are lifting targets in its wake, yet options traders just registered their most defensive positioning of the year — a tension worth…
DexCom heads into its Q1 2026 earnings report with options markets flashing their most cautious signal in months. The put/call ratio jumped to 1.05 on the day of the print — nearly three standard deviations above its…
Options traders are pricing in more pain for DXCM. Three bearish signals converged this week — rising short interest, a spiking put-call ratio, and a higher cost to borrow — all arriving just 12 days before DexCom's…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DXCM — free to start on ORTEX.
Sign up for free →Open DXCM on ORTEX